Hepatitis B Vaccine Clinical Trial
Official title:
An Open, Phase IV, Single-group, Multicentre Study to Assess the Long-term Persistence of Antibodies Against Hepatitis B and the Immune Response to a Hepatitis B (HBV) Vaccine Challenge in Children Aged 7-8 Years of Age and Previously Vaccinated in Infancy With GSK Biologicals' HBV Vaccine (Engerix™-B).
The purpose of this study is to assess the persistence of immunity to hepatitis B in children who received three consecutive doses of HBV vaccine (EngerixTM-B) in infancy. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02991599 -
Immunogenicity of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients
|
Phase 4 | |
Completed |
NCT03316807 -
Immunogenicity of Hepatitis B Vaccination in HIV-infected Adults
|
Phase 4 | |
Completed |
NCT02901951 -
Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-B
|
Phase 4 | |
Not yet recruiting |
NCT03962816 -
Immunogenicity and Persistence of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients
|
Phase 4 | |
Not yet recruiting |
NCT03962881 -
Research on Optimal Immunization Strategy of Hepatitis B Vaccine in Chronic Kidney Disease Population
|
Phase 4 | |
Not yet recruiting |
NCT03962803 -
Immunogenicity and Persistence of Hepatitis B Vaccination in HIV-Infected Patients
|
Phase 4 | |
Completed |
NCT02432430 -
Comparison of Immunization Quality Improvement Dissemination Study
|
N/A | |
Not yet recruiting |
NCT05099757 -
The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students
|
Phase 4 | |
Completed |
NCT02963714 -
Immunogenicity of Hepatitis B Vaccination in Hemodialysis Patients
|
Phase 4 | |
Recruiting |
NCT01590381 -
Assessment of HBV Vaccine Immunity After 18 Years
|
N/A |